Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Greenbaum

Showing results (171-180 of 225) with videos related to

Pageof 23
Sort By:
Diabetes Care|February 20, 2014
Use of the Diabetes Prevention Trial-Type 1 Risk Score (DPTRS) for improving the accuracy of the risk classification of type 1 diabetesJay M Sosenko, Jay S Skyler, Jeffrey Mahon, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|August 24, 2019
Abnormalities in proinsulin processing in islets from individuals with longstanding T1DEmily K Sims, Farooq Syed, Julius Nyalwidhe, et al.
Diabetes Care|October 11, 2019
High Concentration of Medium-Sized HDL Particles and Enrichment in HDL Paraoxonase 1 Associate With Protection From Vascular Complications in People With Long-standing Type 1 DiabetesTomas Vaisar, Jenny E Kanter, Jake Wimberger, et al.
The Journal of Clinical Endocrinology and Metabolism|April 4, 2017
Measurement of Pro-Islet Amyloid Polypeptide (1-48) in Diabetes and Islet TransplantsJaques A Courtade, Agnieszka M Klimek-Abercrombie, Yi-Chun Chen, et al.
Diabetes Care|June 12, 2026
Extended Follow-up of Type 1 Diabetes Immunotherapy Trial Participants Suggests Benign Side Effect ProfileLaura M Jacobsen, Dave Cuthbertson, Jamie Felton, et al.
Diabetes|June 13, 2012
Fall in C-peptide during first 2 years from diagnosis: evidence of at least two distinct phases from composite Type 1 Diabetes TrialNet dataCarla J Greenbaum, Craig A Beam, David Boulware, et al.
The Journal of Clinical Investigation|January 3, 2020
High residual C-peptide likely contributes to glycemic control in type 1 diabetesMichael R Rickels, Carmella Evans-Molina, Henry T Bahnson, et al.
Diabetes|April 15, 2018
Modifying Enzymes Are Elicited by ER Stress, Generating Epitopes That Are Selectively Recognized by CD4<sup>+</sup> T Cells in Patients With Type 1 DiabetesMeghan L Marre, John W McGinty, I-Ting Chow, et al.
Science Translational Medicine|January 12, 2022
Deep immune phenotyping reveals similarities between aging, Down syndrome, and autoimmunityKatharina Lambert, Keagan G Moo, Azlann Arnett, et al.
Nature Communications|April 7, 2022
Citrullination of glucokinase is linked to autoimmune diabetesMei-Ling Yang, Sheryl Horstman, Renelle Gee, et al.
Pageof 23

Showing results (171-180 of 225) with videos related to

Sort By:
Pageof 23
Diabetes Care|February 20, 2014
Use of the Diabetes Prevention Trial-Type 1 Risk Score (DPTRS) for improving the accuracy of the risk classification of type 1 diabetesJay M Sosenko, Jay S Skyler, Jeffrey Mahon, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|August 24, 2019
Abnormalities in proinsulin processing in islets from individuals with longstanding T1DEmily K Sims, Farooq Syed, Julius Nyalwidhe, et al.
Diabetes Care|October 11, 2019
High Concentration of Medium-Sized HDL Particles and Enrichment in HDL Paraoxonase 1 Associate With Protection From Vascular Complications in People With Long-standing Type 1 DiabetesTomas Vaisar, Jenny E Kanter, Jake Wimberger, et al.
The Journal of Clinical Endocrinology and Metabolism|April 4, 2017
Measurement of Pro-Islet Amyloid Polypeptide (1-48) in Diabetes and Islet TransplantsJaques A Courtade, Agnieszka M Klimek-Abercrombie, Yi-Chun Chen, et al.
Diabetes Care|June 12, 2026
Extended Follow-up of Type 1 Diabetes Immunotherapy Trial Participants Suggests Benign Side Effect ProfileLaura M Jacobsen, Dave Cuthbertson, Jamie Felton, et al.
Diabetes|June 13, 2012
Fall in C-peptide during first 2 years from diagnosis: evidence of at least two distinct phases from composite Type 1 Diabetes TrialNet dataCarla J Greenbaum, Craig A Beam, David Boulware, et al.
The Journal of Clinical Investigation|January 3, 2020
High residual C-peptide likely contributes to glycemic control in type 1 diabetesMichael R Rickels, Carmella Evans-Molina, Henry T Bahnson, et al.
Diabetes|April 15, 2018
Modifying Enzymes Are Elicited by ER Stress, Generating Epitopes That Are Selectively Recognized by CD4<sup>+</sup> T Cells in Patients With Type 1 DiabetesMeghan L Marre, John W McGinty, I-Ting Chow, et al.
Science Translational Medicine|January 12, 2022
Deep immune phenotyping reveals similarities between aging, Down syndrome, and autoimmunityKatharina Lambert, Keagan G Moo, Azlann Arnett, et al.
Nature Communications|April 7, 2022
Citrullination of glucokinase is linked to autoimmune diabetesMei-Ling Yang, Sheryl Horstman, Renelle Gee, et al.
Pageof 23